Anterogen.Co.Ltd (065660) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Anterogen.Co.Ltd (065660) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩281.98 Million ≈ $191.09K USD) by net assets (₩90.04 Billion ≈ $61.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Anterogen.Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Anterogen.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Anterogen.Co.Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Anterogen.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anterogen.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dynamic Cables Limited NSE:DYCL	0.012x
AgriFORCE Growing Systems Ltd NASDAQ:AGRI	-0.196x
Hong Leong Capital Bhd KLSE:5274	-0.159x
Windlas Biotech Limited NSE:WINDLAS	0.013x
Polaris Infrastructure Inc TO:PIF	0.052x
Solara Active Pharma Sciences Limited NSE:SOLARA	0.059x
Michlol Finance Ltd TA:MCLL	-0.410x
Greenx Metals Ltd AU:GRX	-0.223x

Annual Cash Flow Conversion Efficiency for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Anterogen.Co.Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see 065660 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩110.21 Billion ≈ $74.69 Million	₩-860.38 Million ≈ $-583.06K	-0.008x	+49.17%
2023-12-31	₩129.44 Billion ≈ $87.72 Million	₩-1.99 Billion ≈ $-1.35 Million	-0.015x	+16.96%
2022-12-31	₩106.79 Billion ≈ $72.37 Million	₩-1.98 Billion ≈ $-1.34 Million	-0.018x	+29.02%
2021-12-31	₩116.87 Billion ≈ $79.20 Million	₩-3.05 Billion ≈ $-2.06 Million	-0.026x	+52.15%
2020-12-31	₩81.07 Billion ≈ $54.94 Million	₩-4.41 Billion ≈ $-2.99 Million	-0.054x	-125.90%
2019-12-31	₩68.39 Billion ≈ $46.35 Million	₩-1.65 Billion ≈ $-1.12 Million	-0.024x	+10.16%
2018-12-31	₩56.07 Billion ≈ $38.00 Million	₩-1.50 Billion ≈ $-1.02 Million	-0.027x	-429.83%
2017-12-31	₩46.61 Billion ≈ $31.58 Million	₩379.21 Million ≈ $256.98K	0.008x	+311.89%
2016-12-31	₩34.02 Billion ≈ $23.06 Million	₩-130.65 Million ≈ $-88.54K	-0.004x	-107.57%
2015-12-31	₩16.64 Billion ≈ $11.28 Million	₩844.49 Million ≈ $572.30K	0.051x	+165.11%
2014-12-31	₩12.96 Billion ≈ $8.78 Million	₩-1.01 Billion ≈ $-684.63K	-0.078x	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$194.04 Million

₩286.33 Billion KRW

Market Cap Rank

#16652 Global

#717 in Korea

Share Price

₩36000.00

Change (1 day)

-4.26%

52-Week Range

₩19850.00 - ₩58000.00

All Time High

₩197700.00